Start for free
Start for free
Osaka University Venture Capital logo

Osaka University Venture Capital

Asia, Osaka, Japan, Osaka

Description

Osaka University Venture Capital focuses on early-stage financing in life innovation, green innovation, and platform technology industry.

Investor Profile

Osaka University Venture Capital has made 9 investments, with 5 in the past 12 months and 11% as lead.

Stage Focus

  • Seed (33%)
  • Series B (22%)
  • Series A (11%)
  • Series D (11%)
  • Series C (11%)
  • Series Unknown (11%)

Country Focus

  • Japan (100%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Health Care
  • Life Science
  • Medical
  • Nursing And Residential Care
  • Product Research
  • Pharmaceutical
  • Manufacturing
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Osaka University Venture Capital frequently co-invest with?

RV
Remiges Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
SkyDeck Berkeley
SkyDeck Berkeley
North America, California, United States, Berkeley
Co-Investments: 1
Kyoto University Innovation Capital
Kyoto University Innovation Capital
Asia, Kyoto, Japan, Kyoto
Co-Investments: 2
JIC Venture Growth Investments
JIC Venture Growth Investments
Asia, Tokyo, Japan, Marunouchi
Co-Investments: 2
F-Prime Capital
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Berkeley SkyDeck Fund
Berkeley SkyDeck Fund
North America, California, United States, Berkeley
Co-Investments: 1
Japan Science and Technology Agency
Japan Science and Technology Agency
Asia, Saitama, Japan, Kawaguchi
Co-Investments: 1
SBI Group
SBI Group
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Mitsubishi UFJ Capital
Mitsubishi UFJ Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 3

What are some of recent deals done by Osaka University Venture Capital?

Ayumo

Osaka, Osaka, Japan

Ayumo is a research and development company that provides deep learning services with medical insights and AI technology.

Artificial Intelligence (AI)Market ResearchMedical
SeedApr 15, 2025
Amount Raised: $697,364
RegCell

Osaka, Osaka, Japan

RegCell is a novel therapeutics company.

Alternative MedicineClinical TrialsOutpatient Care
SeedMar 18, 2025
Amount Raised: $8,500,000
QunaSys

Tokyo, Tokyo, Japan

QunaSys is a research and development company that provides design, benchmark, and analyze software using quantum computers.

ComputerConsultingInformation TechnologyQuantum ComputingSoftware
Series BNov 1, 2024
Amount Raised: $11,109,296
A-Wave

Osaka-shi, Osaka, Japan

A-Wave is a manufacturing company that develops and markets medical devices, pharmaceuticals, computer software, and hardware.

Health CareManufacturingMedical Device
Series UnknownOct 15, 2024
Amount Raised: $1,341,492
Alpha Fusion

Osaka, Osaka, Japan

Alpha Fusion produces astatine based radiopharmaceuticals for targeted alpha therapy.

MedicalPharmaceuticalTherapeutics
Series BOct 8, 2024
Amount Raised: $6,885,228
Luxna Biotech

Osaka, Osaka, Japan

Luxana Biotech is established to contribute to medical treatment for suffering patients, .

BiotechnologyHealth CareProduct Research
Series CSep 6, 2024
Amount Raised: $1,686,282
Restore Vision

Tokyo, Tokyo, Japan

Restore Vision is a biotechnology company developing a visual restoration gene therapy for retinitis pigmentosa.

BiotechnologyHealth CareTherapeutics
Series ADec 15, 2023
Amount Raised: $4,221,636
J-Pharma

Yokohama, Kanagawa, Japan

J-Pharma is biotechnology company mission is to creating and developing novel pharmaceuticals.

BiotechnologyMedicalNursing and Residential Care
Series DJul 30, 2020
Amount Raised: $16,678
ThinkCyte

Hongo, Tokyo, Japan

ThinkCyte provides single-cell analysis for research, diagnostics, and therapeutics with an integrated multidisciplinary approach.

BiotechnologyLife ScienceTherapeutics
SeedMar 15, 2019
Amount Raised: $2,692,065
ThinkCyte

Hongo, Tokyo, Japan

ThinkCyte provides single-cell analysis for research, diagnostics, and therapeutics with an integrated multidisciplinary approach.

BiotechnologyLife ScienceTherapeutics
SeedJun 15, 2018
Amount Raised: $3,162,412
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsNewsletterPricing

Free tools

Pre-Money and Post-Money Valuation Calculator